Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
Abstract Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID‐19 vaccination. She was treated with a combination of romiplostim and mycophenolate mof...
Enregistré dans:
Auteurs principaux: | Snigdha Nutalapati, Garima Gupta, Gerhard C. Hildebrandt |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1437eade9ac94ff394c89f134275467c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Topical mycophenolate mofetil in the treatment of vitiligo: a pilot study
par: Farhad Handjani, et autres
Publié: (2017) -
Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease
par: ZHANG,TONG, et autres
Publié: (2009) -
Atrofia vellositaria duodenal inducida por micofenolato mofetil: Caso clínico
par: TAPIA E,OSCAR, et autres
Publié: (2010) -
Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant
par: Iqbal A, et autres
Publié: (2020) -
Estudio de biodisponibilidad relativa entre dos formulaciones orales de micofenolato mofetilo en voluntarios sanos
par: Saavedra S,Iván, et autres
Publié: (2011)